Printer Friendly

IMS HEALTH SIGNS WYETH LEDERLE PORTUGAL FOR PRM.

IMS HEALTH (NYSE: RX) has announced that its Strategic Technologies unit will implement leading-edge Pharmaceutical Relationship Management (PRM) solutions for Wyeth Lederle Portugal. The multi-year contract was awarded following an analysis of technology-enabled selling solutions for the pharmaceutical industry, and a competitive bidding process. Wyeth Lederle Portugal will deploy IMS HEALTH Strategic Technologies' Premiere(SM) customer relationship management technology to maximize the effectiveness and productivity of its sales representatives throughout Portugal. IMS HEALTH is the world's leading provider of information solutions to the pharmaceutical and healthcare industries.

IMS HEALTH Strategic Technologies' Premiere pharmaceutical relationship management technology enables pharmaceutical field sales representatives, district managers and headquarters executives to access mission-critical sales, contact and territory information via desktop, laptop or handheld PC's. Up-to-the minute information fed to pharmaceutical sales and marketing forces by Premiere enables faster and better informed sales and marketing decisions, enhancing return-on-investment in customer relationship activities.

Through a unique combination of tailored and integrated software, customer databases and expert service and support, IMS HEALTH Strategic Technologies is the global market leader in the implementation of customized Pharmaceutical Relationship Management (PRM) solutions. PRM is IMS HEALTH Strategic Technologies' proprietary adaptation of customer relationship management technologies to meet the specific needs of the pharmaceutical industry. IMS HEALTH Strategic Technologies focuses solely on the pharmaceutical industry, using its unmatched industry knowledge to implement effective solutions that help clients achieve maximum return on their sales and marketing investments.

IMS HEALTH is the world's leading provider of information solutions to the pharmaceutical and healthcare industries. With $1.4 billion in 1999 revenue, IMS HEALTH operates in over 100 countries. IMS HEALTH is the largest pharmaceutical manufacturer information partner, with over 40 years' experience in the industry. Key products and services integral to customer day-to-day operations include: market research for prescription and over-the-counter pharmaceutical products; sales management information to optimize sales force productivity; pharmaceutical relationship management solutions for sales and marketing decision-making; and technology systems and information services that support managed care organizations.

For more information, visit http://www.imshealth.com or call +44 171 393-5864.
COPYRIGHT 2000 Worldwide Videotex
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Pharmaceutical Relationship Management
Comment:IMS HEALTH SIGNS WYETH LEDERLE PORTUGAL FOR PRM.(Pharmaceutical Relationship Management)
Publication:Worldwide Biotech
Article Type:Brief Article
Geographic Code:1USA
Date:Jun 1, 2000
Words:341
Previous Article:BIOHYBRID GETS ANOTHER MILESTONE PAYMENT FROM MICROMET GMBH.
Next Article:FDA APPROVES TARO'S ANDA FOR DIFLORASONE DIACETATE CREAM.
Topics:


Related Articles
TheraTech and Wyeth-Ayerst enter into testosterone marketing agreement.
IMS HEALTH Strategic Technologies Signs AstraZeneca Operations in Italy for its Pharbase and Premiere Pharmaceutical Relationship Management...
IMS HEALTH Strategic Technologies to Implement Pharmaceutical Relationship Management Solutions for DuPont Pharmaceuticals Limited in the U.K.
IMS HEALTH Strategic Technologies Signs European Vendor Agreement With Roche; Premiere Pharmaceutical Relationship Management Solution To Be...
IMS HEALTH Strategic Technologies Signs Aventis in Spain for Pharbase and Premiere Pharmaceutical Relationship Management Solutions.
IMS HEALTH Signs Multi-Year Agreement to Provide Pharbase Database Services to Eli Lilly and Company S.A. in Spain.
IMS HEALTH Strategic Technologies Signs Wyeth Lederle Portugal for Premiere Pharmaceutical Relationship Management Solutions.
IMS HEALTH Strategic Technologies Signs Three-year Agreement With Alter Farma in Portugal for Premiere Pharmaceutical Relationship Management...
MEDICAL DATABASE MARKETS PHARMACEUTICALS INTERNATIONALLY.
IMS HEALTH Strategic Technologies Signs Bristol-Myers Squibb for Pharmaceutical Relationship Management Solutions in the U.K.

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters